2. Academic Validation
  3. Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer

Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer

  • J Cancer Res Clin Oncol. 2007 Apr;133(4):213-8. doi: 10.1007/s00432-006-0159-8.
J Akaishi 1,  M Onda,  J Okamoto,  S Miyamoto,  M Nagahama,  K Ito,  A Yoshida,  K Shimizu
Affiliations

Affiliation

  • 1 Department of Molecular Biology, Institute of Gerontology. Nippon Medical School, Kawasaki 211-8533, Japan. s4067@nms.ac.jp
PMID: 17072649 DOI: 10.1007/s00432-006-0159-8
Abstract

Purpose: Ansaplastic thyroid Cancer (ATC) is one of the most lethal malignancies, but the carcinogenic mechanism of ATC has not been clarified. Recently, we performed a cDNA microarray analysis and identified transmembrane protein 34 (TMEM34) that down-regulated in anaplastic thyroid Cancer cell lines (ACL)s as compared to normal thyroid tissues.

Methods: To investigate the role of TMEM34 in ATC carcinogenesis, we examined expression levels of TMEM34 in ACLs as well as differentiated thyroid cancers (DTC)s and normal human tissues. To explore the effect of TMEM34 in ATC development, cell-growth assays with KTA2 cells were performed.

Results: Expression of TMEM34 was down-regulated in all 11 ACLs, as compared to either normal thyroid tissues or cell lines derived from papillary or follicular thyroid cancers. TMEM34 was expressed ubiquitously in normal human tissues tested. Transfection of TMEM34 into KTA2 cells led to inhibition of cell growth.

Conclusions: Our findings suggest that TMEM34 might be a tumor suppressor gene, associated with the development of ATC from DTC.

Figures